421 related articles for article (PubMed ID: 18348597)
1. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH; Lönnqvist J; Juva K; Alho H
J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
[TBL] [Abstract][Full Text] [Related]
2. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
Muhonen LH; Lahti J; Sinclair D; Lönnqvist J; Alho H
Subst Abuse Treat Prev Policy; 2008 Oct; 3():20. PubMed ID: 18834506
[TBL] [Abstract][Full Text] [Related]
3. Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.
Muhonen LH; Lönnqvist J; Lahti J; Alho H
Psychiatry Res; 2009 May; 167(1-2):115-22. PubMed ID: 19346004
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH; Lahti J; Alho H; Lönnqvist J; Haukka J; Saarikoski ST
Psychiatry Res; 2011 Mar; 186(1):53-7. PubMed ID: 20800901
[TBL] [Abstract][Full Text] [Related]
6. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
Mohamed S; Osatuke K; Aslam M; Kasckow J
Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial.
Smith EG; Deligiannidis KM; Ulbricht CM; Landolin CS; Patel JK; Rothschild AJ
J Clin Psychiatry; 2013 Oct; 74(10):966-73. PubMed ID: 24229746
[TBL] [Abstract][Full Text] [Related]
9. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
10. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints.
Lavretsky H; Laird KT; Krause-Sorio B; Heimberg BF; Yeargin J; Grzenda A; Wu P; Thana-Udom K; Ercoli LM; Siddarth P
Am J Geriatr Psychiatry; 2020 Feb; 28(2):178-190. PubMed ID: 31519517
[TBL] [Abstract][Full Text] [Related]
12. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
13. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
Han DH; Kim SM; Choi JE; Min KJ; Renshaw PF
J Psychopharmacol; 2013 Mar; 27(3):282-91. PubMed ID: 23325372
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
19. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
